• Home
  • 77th Annual Meeting of the American Academy of Neurology

AAN 2025


San Diego

77th Annual Meeting of the American Academy of Neurology
Explore more Sleep congress materials
Material Type

Results(7)

Neuroscience
Effectiveness and Safety of Low-Sodium Oxybate in Participants With Narcolepsy or Idiopathic Hypersomnia: Top-line Results From the Phase 4 DUET Study
Author(s): Logan D. Schneider, David T. Plante, Deborah A. Nichols et al.
Self-Reported Cognitive Complaints and Work Productivity in Participants With Narcolepsy or Idiopathic Hypersomnia After Low-Sodium Oxybate Treatment: Results From the Phase 4 DUET Study
Author(s): Logan D. Schneider, Chad M. Ruoff, Deborah A. Nichols et al.
Efficacy and Safety of Low-Sodium Oxybate in Narcolepsy Patients With/Without Psychiatric/Neurologic Comorbidities
Author(s): Craig Chepke, Andrew J. Cutler, Nathaniel F. Watson et al.
Nurse-Reported Outcomes of Cannabidiol (CBD) Treatment in the Long-Term Care (LTC) Setting: Results From the BECOME-LTC Survey
Author(s): Nanette Wrobel, Jason Shafrin, Andrea Chung et al.
Caregiver-Reported Real-World Use of Cannabidiol (CBD) and Effects on Seizures and Caregiver Burden: Results From the CARE-EpiC Survey
Author(s): Sheila M. Thomas, James McAuley, Christopher Jones et al.
Tuberous Sclerosis Complex (TSC)–Associated Neuropsychiatric Disorder (TAND) Outcomes Following Add-on Cannabidiol (CBD) Treatment: 3-Month Analysis of Open-Label Phase 3b/4 Trial EpiCom
Author(s): Agnies van Eeghen, Sarah M.L. Wilson, Douglas M. Smith et al.
Dosing Patterns and Persistence on Cannabidiol (CBD): Insights From US Specialty Pharmacy Data
Author(s): Gerhardt Pohl, Leah Burn, Shuo (Serena) Cao et al.